Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are conducting an international observational study to better understand acute infections in adults who are hospitalized. This study focuses on patients with suspected or confirmed acute infectious diseases, including respiratory infections and emerging infectious diseases. The goal is to gather data and biospecimens that will help characterize these infections, identify risk factors, and inform future clinical trial designs. Participants in this study do not receive any experimental treatments as it is purely observational. The study collects detailed clinical data and biological samples from adults admitted to hospitals with acute infections. This includes patients with symptoms starting within the last 30 days. Data from multiple global sites will aid in comprehensively understanding the clinical course and management of these infections. During the study, participants health status will be monitored through various clinical assessments over a 28-day period. Researchers will measure outcomes such as mortality, recovery time, clinical improvement, organ support days, and organ failure scores. The study involves informed consent and follows participants during hospitalization and recovery to gather important information about acute infectious diseases and their progression.
Actively Recruiting
Researchers are studying meningitis in northern Uganda to understand its causes, burden, diagnosis, treatment, and prevention. They aim to identify gaps in care and support the use of routine vaccinations for bacterial meningitis and improved screening for cryptococcal meningitis in HIV-positive patients. This study focuses on collecting detailed data to help improve meningitis care and outcomes in this region. Participants include patients showing meningitis symptoms at Lira Regional Referral Hospital or nearby clinics. The study uses advanced diagnostic tests like the cryptococcal antigen lateral flow assay, Pastorex antigen agglutination assay, and Biofire PCR to identify infectious agents. The research involves screening 1,100 patients with meningitis symptoms and 10,000 HIV-positive patients for cryptococcal antigenemia over a two-year period. During the study, participants undergo diagnostic testing, and researchers track outcomes such as deaths during hospitalization and up to 24 months after admission. They also monitor the development of cryptococcal meningitis and mortality among those affected. The study provides important data on meningitis burden and diagnostic accuracy, with a focus on improving prevention and treatment strategies in Uganda.
Actively Recruiting
Researchers are evaluating whether taking azithromycin as a preventive treatment can reduce the risk of death in adults with advanced HIV disease. This is a Phase 3, double-blind, placebo-controlled trial involving multiple centers. The study aims to understand if azithromycin prophylaxis can lower mortality compared to a placebo in this vulnerable population. Participants will be randomly assigned to receive either an oral azithromycin tablet or a matching placebo tablet once daily for 28 days. After this treatment period, they will be followed for 24 weeks to measure the main outcome of all-cause mortality. The total study participation will last 48 weeks to monitor both short-term and longer-term effects. During the study, participants will undergo assessments to track survival and hospitalizations at 12 and 24 weeks after starting the treatment. Researchers will closely monitor health outcomes and any hospital stays to evaluate the impact of azithromycin prophylaxis. Safety and adherence will be followed throughout the trial to ensure accurate measurement of results.